デフォルト表紙
市場調査レポート
商品コード
1591905

ヒアルロン酸市場:グレード、製剤、用途、流通別-2025-2030年の世界予測

Hyaluronic Acid Market by Grade (Cosmetic Grade, Food Grade, Medical Grade), Formulation (HA, HA + Lidocaine), Application, Distribution - Global Forecast 2025-2030


出版日
発行
360iResearch
ページ情報
英文 190 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.30円
ヒアルロン酸市場:グレード、製剤、用途、流通別-2025-2030年の世界予測
出版日: 2024年10月31日
発行: 360iResearch
ページ情報: 英文 190 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ヒアルロン酸市場は2023年に98億3,000万米ドルと評価され、2024年には107億7,000万米ドルに達すると予測され、CAGR 9.61%で成長し、2030年には187億1,000万米ドルになると予測されています。

ヒアルロン酸(HA)は人体に天然に存在する物質で、水分を保持する能力で知られ、化粧品、医薬品、栄養補助食品産業において不可欠なものとなっています。HAの必要性はその保湿性に由来し、皮膚の健康、関節の潤滑、創傷治癒に不可欠です。HAの用途は、アンチエイジングと保湿のための化粧品、変形性関節症治療と眼科手術のための医薬品、そして皮膚と関節の健康のための栄養補助食品に及ぶ。その最終用途の範囲は広く、化粧品産業、ヘルスケアプロバイダー、栄養補助食品メーカーが需要を牽引しています。HA市場は、スキンケアへの注目の高まり、変形性関節症の有病率の上昇、外科手術を伴わない美容整形に対する消費者の嗜好などから成長を遂げています。主要な促進要因は、高齢化人口であり、HAのアンチエイジング効果を補完し、HAの生産と配合を強化する技術の進歩です。その他の活動の可能性は、標的ドラッグデリバリーシステムのような医薬品分野での応用拡大や、HAと他の有効成分を組み合わせた革新的な化粧品処方の開発にあります。しかしながら市場成長は、高い生産コスト、先進地域での市場飽和、規制上のハードルといった要因に阻まれています。これらを軽減するために、企業はコスト効率の良い生産技術に投資し、ヘルスケアインフラが発展している新興国市場を開拓する必要があります。革新的な研究分野としては、浸透能力を高めた改良型HA製剤のバイオエンジニアリング、再生医療のためのCRISPRのような最先端技術と組み合わせたHAの探求、獣医学のような新しい分野でのHA応用の開発などがあります。HA市場は、天然由来の製品に対する消費者の需要に後押しされ、革新への強い傾斜を持ったダイナミックな市場です。ユニークな製品の提供と持続可能な製造方法を通して市場の差別化を達成することは、ビジネス成長の大きな可能性を示します。企業は、技術的進歩を活用し、規制上の障壁に効果的に対処するために、研究開発投資と戦略的パートナーシップの強化に重点を置くべきです。

主な市場の統計
基準年[2023] 98億3,000万米ドル
予測年[2024] 107億7,000万米ドル
予測年[2030] 187億1,000万米ドル
CAGR(%) 9.61%

市場力学:急速に進化するヒアルロン酸市場の主要市場インサイトを公開

ヒアルロン酸市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

  • 市場促進要因
    • 非外科的美容施術の採用
    • スキンケア製品における保湿剤としてのヒアルロン酸の役割の増大
    • 変形性関節症治療における関節内補充療法への需要の高まり
  • 市場抑制要因
    • 関節内補充療法製品の有効性に関する懸念の高まり
  • 市場機会
    • ヒアルロン酸調査への注力
    • HA官能基化に基づく新しいアプリケーションの創出
  • 市場の課題
    • ヒアルロン酸の副作用のリスク

ポーターの5つの力:ヒアルロン酸市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、ヒアルロン酸市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析:ヒアルロン酸市場における外部からの影響の把握

外部マクロ環境要因は、ヒアルロン酸市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析ヒアルロン酸市場における競合情勢の把握

ヒアルロン酸市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスヒアルロン酸市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、ヒアルロン酸市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨ヒアルロン酸市場における成功への道筋を描く

ヒアルロン酸市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています:

1.市場の浸透度:現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度:新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化:最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報:競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション:将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています:

1.現在の市場規模と今後の成長予測は?

2.最高の投資機会を提供する製品、セグメント、地域はどこか?

3.市場を形成する主な技術動向と規制の影響とは?

4.主要ベンダーの市場シェアと競合ポジションは?

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 非外科的美容処置の導入
      • スキンケア製品における保湿剤としてのヒアルロン酸の役割の増大
      • 変形性関節症治療における関節内補充療法の需要増加
    • 抑制要因
      • 関節内補充療法製品の有効性に関する懸念の高まり
    • 機会
      • ヒアルロン酸調査への取り組み
      • HA機能に基づく新しいアプリケーションの作成
    • 課題
      • ヒアルロン酸の副作用のリスク
  • 市場セグメンテーション分析
  • ポーターのファイブフォース分析
  • PESTEL分析
    • 政治的
    • 経済
    • 社交
    • 技術的
    • 法律上
    • 環境

第6章 ヒアルロン酸市場:グレード別

  • 化粧品グレード
  • 食品グレード
  • 医療グレード

第7章 ヒアルロン酸市場処方別

  • HA
  • HA+リドカイン

第8章 ヒアルロン酸市場:用途別

  • 美学
  • 化粧品
  • 栄養補助食品
  • 眼科
  • 変形性関節症
  • 医薬品API

第9章 ヒアルロン酸市場配布元

  • 病院
  • オンライン薬局
  • 小売薬局
  • 専門クリニック

第10章 南北アメリカのヒアルロン酸市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域のヒアルロン酸市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカのヒアルロン酸市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • 市場シェア分析2023
  • FPNVポジショニングマトリックス, 2023
  • 競合シナリオ分析
  • 戦略分析と提言

企業一覧

  • Abbvie Inc.
  • Anika Therapeutics, Inc.
  • Bausch & Lomb Incorporated
  • Bioiberica S.A.U.
  • Bloomage BioTechnology Corporation Limited
  • Contipro a.s.
  • Evonik Industries AG
  • Ferring Pharmaceuticals, Inc.
  • Fidia Farmaceutici S.p.A.
  • Galderma S.A.
  • HTL Biotechnology
  • Kewpie Corporation
  • Kikkoman Biochemifa Company
  • La Roche-Posay
  • LG Chem Ltd.
  • Lifecore Biomedical, LLC
  • Maruha Nichiro Corporation
  • Sanofi S.A.
  • Seikagaku Corporation
  • Shiseido Company, Limited
  • Smith & Nephew PLC
  • Zimmer Biomet
図表

LIST OF FIGURES

  • FIGURE 1. HYALURONIC ACID MARKET RESEARCH PROCESS
  • FIGURE 2. HYALURONIC ACID MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HYALURONIC ACID MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HYALURONIC ACID MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL HYALURONIC ACID MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL HYALURONIC ACID MARKET SIZE, BY GRADE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL HYALURONIC ACID MARKET SIZE, BY GRADE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL HYALURONIC ACID MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL HYALURONIC ACID MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL HYALURONIC ACID MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL HYALURONIC ACID MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL HYALURONIC ACID MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL HYALURONIC ACID MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS HYALURONIC ACID MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS HYALURONIC ACID MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES HYALURONIC ACID MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES HYALURONIC ACID MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC HYALURONIC ACID MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC HYALURONIC ACID MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HYALURONIC ACID MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA HYALURONIC ACID MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. HYALURONIC ACID MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. HYALURONIC ACID MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HYALURONIC ACID MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HYALURONIC ACID MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HYALURONIC ACID MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL HYALURONIC ACID MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. HYALURONIC ACID MARKET DYNAMICS
  • TABLE 7. GLOBAL HYALURONIC ACID MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL HYALURONIC ACID MARKET SIZE, BY COSMETIC GRADE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL HYALURONIC ACID MARKET SIZE, BY FOOD GRADE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL HYALURONIC ACID MARKET SIZE, BY MEDICAL GRADE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL HYALURONIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL HYALURONIC ACID MARKET SIZE, BY HA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL HYALURONIC ACID MARKET SIZE, BY HA + LIDOCAINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL HYALURONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL HYALURONIC ACID MARKET SIZE, BY AESTHETICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL HYALURONIC ACID MARKET SIZE, BY COSMETICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL HYALURONIC ACID MARKET SIZE, BY DIETARY SUPPLEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL HYALURONIC ACID MARKET SIZE, BY OPTHALMOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL HYALURONIC ACID MARKET SIZE, BY OSTEOARTHRISTIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL HYALURONIC ACID MARKET SIZE, BY PHARMACEUTICAL API, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL HYALURONIC ACID MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL HYALURONIC ACID MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL HYALURONIC ACID MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL HYALURONIC ACID MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL HYALURONIC ACID MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS HYALURONIC ACID MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS HYALURONIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS HYALURONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS HYALURONIC ACID MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS HYALURONIC ACID MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA HYALURONIC ACID MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA HYALURONIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA HYALURONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA HYALURONIC ACID MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL HYALURONIC ACID MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL HYALURONIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL HYALURONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL HYALURONIC ACID MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA HYALURONIC ACID MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA HYALURONIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA HYALURONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA HYALURONIC ACID MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO HYALURONIC ACID MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO HYALURONIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO HYALURONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO HYALURONIC ACID MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES HYALURONIC ACID MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES HYALURONIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES HYALURONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES HYALURONIC ACID MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES HYALURONIC ACID MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC HYALURONIC ACID MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC HYALURONIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC HYALURONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC HYALURONIC ACID MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC HYALURONIC ACID MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA HYALURONIC ACID MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA HYALURONIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA HYALURONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA HYALURONIC ACID MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA HYALURONIC ACID MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA HYALURONIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA HYALURONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA HYALURONIC ACID MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA HYALURONIC ACID MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA HYALURONIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA HYALURONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA HYALURONIC ACID MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA HYALURONIC ACID MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA HYALURONIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA HYALURONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA HYALURONIC ACID MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN HYALURONIC ACID MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN HYALURONIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN HYALURONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN HYALURONIC ACID MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA HYALURONIC ACID MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA HYALURONIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA HYALURONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA HYALURONIC ACID MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES HYALURONIC ACID MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES HYALURONIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES HYALURONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES HYALURONIC ACID MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE HYALURONIC ACID MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE HYALURONIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE HYALURONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE HYALURONIC ACID MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA HYALURONIC ACID MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA HYALURONIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA HYALURONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA HYALURONIC ACID MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN HYALURONIC ACID MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN HYALURONIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN HYALURONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN HYALURONIC ACID MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND HYALURONIC ACID MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND HYALURONIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND HYALURONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND HYALURONIC ACID MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM HYALURONIC ACID MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM HYALURONIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM HYALURONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM HYALURONIC ACID MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA HYALURONIC ACID MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA HYALURONIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA HYALURONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA HYALURONIC ACID MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA HYALURONIC ACID MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK HYALURONIC ACID MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK HYALURONIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK HYALURONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK HYALURONIC ACID MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT HYALURONIC ACID MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT HYALURONIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT HYALURONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT HYALURONIC ACID MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND HYALURONIC ACID MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND HYALURONIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND HYALURONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND HYALURONIC ACID MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE HYALURONIC ACID MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE HYALURONIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE HYALURONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE HYALURONIC ACID MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY HYALURONIC ACID MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY HYALURONIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY HYALURONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY HYALURONIC ACID MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL HYALURONIC ACID MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL HYALURONIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL HYALURONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL HYALURONIC ACID MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY HYALURONIC ACID MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY HYALURONIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY HYALURONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY HYALURONIC ACID MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS HYALURONIC ACID MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS HYALURONIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS HYALURONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS HYALURONIC ACID MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA HYALURONIC ACID MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA HYALURONIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA HYALURONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA HYALURONIC ACID MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY HYALURONIC ACID MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY HYALURONIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY HYALURONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY HYALURONIC ACID MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND HYALURONIC ACID MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND HYALURONIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND HYALURONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND HYALURONIC ACID MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR HYALURONIC ACID MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR HYALURONIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR HYALURONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR HYALURONIC ACID MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA HYALURONIC ACID MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA HYALURONIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA HYALURONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA HYALURONIC ACID MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA HYALURONIC ACID MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA HYALURONIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA HYALURONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA HYALURONIC ACID MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA HYALURONIC ACID MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA HYALURONIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA HYALURONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA HYALURONIC ACID MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN HYALURONIC ACID MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN HYALURONIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN HYALURONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN HYALURONIC ACID MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN HYALURONIC ACID MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN HYALURONIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN HYALURONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN HYALURONIC ACID MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND HYALURONIC ACID MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND HYALURONIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND HYALURONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND HYALURONIC ACID MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY HYALURONIC ACID MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY HYALURONIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY HYALURONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY HYALURONIC ACID MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES HYALURONIC ACID MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES HYALURONIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES HYALURONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES HYALURONIC ACID MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM HYALURONIC ACID MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM HYALURONIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM HYALURONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM HYALURONIC ACID MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 194. HYALURONIC ACID MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 195. HYALURONIC ACID MARKET, FPNV POSITIONING MATRIX, 2023
目次
Product Code: MRR-43127F7278F2

The Hyaluronic Acid Market was valued at USD 9.83 billion in 2023, expected to reach USD 10.77 billion in 2024, and is projected to grow at a CAGR of 9.61%, to USD 18.71 billion by 2030.

Hyaluronic Acid (HA) is a naturally occurring substance in the human body known for its ability to retain moisture, making it vital in the cosmetic, pharmaceutical, and dietary supplement industries. The necessity of HA stems from its hydrating properties, which are essential for skin health, joint lubrication, and wound healing. HA applications span cosmetics for anti-aging and hydration, pharmaceuticals for osteoarthritis treatment and eye surgery, and dietary supplements for skin and joint health. Its end-use scope is extensive, with demand driven by the cosmetic industry, healthcare providers, and dietary supplement manufacturers. The HA market experiences growth due to an increasing focus on skincare, rising prevalence of osteoarthritis, and consumer preference for non-surgical cosmetic procedures. A key growth driver is the aging population, complementing HA's anti-aging benefits, and technological advancements enhancing HA production and formulation. Potential opportunities lie in expanding applications within the pharmaceutical realm, such as targeted drug delivery systems, and developing innovative cosmetic formulations combining HA with other active ingredients. However, market growth is challenged by factors like high production costs, market saturation in developed regions, and regulatory hurdles. To mitigate these, companies need to invest in cost-effective production technologies and explore emerging markets with developing healthcare infrastructures. Innovative areas for research include bioengineering improved HA formulations with enhanced penetration capabilities, exploring HA in conjunction with cutting-edge technologies like CRISPR for regenerative medicine, and developing HA applications in novel areas like veterinary medicine. The HA market is dynamic with a strong inclination towards innovation, driven by consumer demand for naturally derived products. Achieving market differentiation through unique product offerings and sustainable manufacturing practices presents significant potential for business growth. Companies should focus on intensifying R&D investments and strategic partnerships to leverage technological advancements and address regulatory barriers effectively.

KEY MARKET STATISTICS
Base Year [2023] USD 9.83 billion
Estimated Year [2024] USD 10.77 billion
Forecast Year [2030] USD 18.71 billion
CAGR (%) 9.61%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Hyaluronic Acid Market

The Hyaluronic Acid Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Adoption of Non-surgical Cosmetic Procedures
    • Increasing Role of Hyaluronic Acid as Humectant in Skin Care Products
    • Growing Demand for Viscosupplementation for Osteoarthritis Treatment
  • Market Restraints
    • Increasing Concerns Regarding the Efficacy of Viscosupplementation Products
  • Market Opportunities
    • Focus Efforts Towards Hyaluronic Acid Research
    • Creating New Applications Based On HA Functionalization
  • Market Challenges
    • Risk of side effects of hyaluronic acid

Porter's Five Forces: A Strategic Tool for Navigating the Hyaluronic Acid Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Hyaluronic Acid Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Hyaluronic Acid Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Hyaluronic Acid Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Hyaluronic Acid Market

A detailed market share analysis in the Hyaluronic Acid Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Hyaluronic Acid Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Hyaluronic Acid Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Hyaluronic Acid Market

A strategic analysis of the Hyaluronic Acid Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Hyaluronic Acid Market, highlighting leading vendors and their innovative profiles. These include Abbvie Inc., Anika Therapeutics, Inc., Bausch & Lomb Incorporated, Bioiberica S.A.U., Bloomage BioTechnology Corporation Limited, Contipro a.s., Evonik Industries AG, Ferring Pharmaceuticals, Inc., Fidia Farmaceutici S.p.A., Galderma S.A., HTL Biotechnology, Kewpie Corporation, Kikkoman Biochemifa Company, La Roche-Posay, LG Chem Ltd., Lifecore Biomedical, LLC, Maruha Nichiro Corporation, Sanofi S.A., Seikagaku Corporation, Shiseido Company, Limited, Smith & Nephew PLC, and Zimmer Biomet.

Market Segmentation & Coverage

This research report categorizes the Hyaluronic Acid Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Grade, market is studied across Cosmetic Grade, Food Grade, and Medical Grade.
  • Based on Formulation, market is studied across HA and HA + Lidocaine.
  • Based on Application, market is studied across Aesthetics, Cosmetics, Dietary Supplement, Opthalmology, Osteoarthristis, and Pharmaceutical API.
  • Based on Distribution, market is studied across Hospitals, Online Pharmacies, Retail Pharmacies, and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Adoption of Non-surgical Cosmetic Procedures
      • 5.1.1.2. Increasing Role of Hyaluronic Acid as Humectant in Skin Care Products
      • 5.1.1.3. Growing Demand for Viscosupplementation for Osteoarthritis Treatment
    • 5.1.2. Restraints
      • 5.1.2.1. Increasing Concerns Regarding the Efficacy of Viscosupplementation Products
    • 5.1.3. Opportunities
      • 5.1.3.1. Focus Efforts Towards Hyaluronic Acid Research
      • 5.1.3.2. Creating New Applications Based On HA Functionalization
    • 5.1.4. Challenges
      • 5.1.4.1. Risk of side effects of hyaluronic acid
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Hyaluronic Acid Market, by Grade

  • 6.1. Introduction
  • 6.2. Cosmetic Grade
  • 6.3. Food Grade
  • 6.4. Medical Grade

7. Hyaluronic Acid Market, by Formulation

  • 7.1. Introduction
  • 7.2. HA
  • 7.3. HA + Lidocaine

8. Hyaluronic Acid Market, by Application

  • 8.1. Introduction
  • 8.2. Aesthetics
  • 8.3. Cosmetics
  • 8.4. Dietary Supplement
  • 8.5. Opthalmology
  • 8.6. Osteoarthristis
  • 8.7. Pharmaceutical API

9. Hyaluronic Acid Market, by Distribution

  • 9.1. Introduction
  • 9.2. Hospitals
  • 9.3. Online Pharmacies
  • 9.4. Retail Pharmacies
  • 9.5. Specialty Clinics

10. Americas Hyaluronic Acid Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Hyaluronic Acid Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Hyaluronic Acid Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbvie Inc.
  • 2. Anika Therapeutics, Inc.
  • 3. Bausch & Lomb Incorporated
  • 4. Bioiberica S.A.U.
  • 5. Bloomage BioTechnology Corporation Limited
  • 6. Contipro a.s.
  • 7. Evonik Industries AG
  • 8. Ferring Pharmaceuticals, Inc.
  • 9. Fidia Farmaceutici S.p.A.
  • 10. Galderma S.A.
  • 11. HTL Biotechnology
  • 12. Kewpie Corporation
  • 13. Kikkoman Biochemifa Company
  • 14. La Roche-Posay
  • 15. LG Chem Ltd.
  • 16. Lifecore Biomedical, LLC
  • 17. Maruha Nichiro Corporation
  • 18. Sanofi S.A.
  • 19. Seikagaku Corporation
  • 20. Shiseido Company, Limited
  • 21. Smith & Nephew PLC
  • 22. Zimmer Biomet